Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company ...

Breathing—a natural and essential process—can be an incredibly labored process for people with cystic fibrosis. CF, a genetic ...

Vertex Pharmaceuticals (NasdaqGS:VRTX) presented promising clinical data on their CFTR modulator ALYFTREK at the European Cystic Fibrosis Conference, showcasing improved outcomes for patients with ...

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) has announced data across multiple studies demonstrating positive clinical ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive ...

Sionna Therapeutics shares rose after reporting positive preliminary data from its cystic fibrosis drug trial. Shares traded 5.9% higher at $16.92.

The 30th annual Battle Against Cystic Fibrosis football game will be held this Friday to raise money for Cystic Fibrosis ...

will be presented at the European Cystic Fibrosis Society’s conference in Milan from June 4-7, 2025. The presentation will explore how these NBD1 stabilizers can synergize with CFTR modulators ...

48th European Cystic Fibrosis Conference, being held June 4-7, 2025 in Milan, Italy. Details of the oral presentation are as follows: Abstract Title: Stabilizers of CFTR NBD1 synergize with ...

48 th European Cystic Fibrosis Conference, being held June 4-7, 2025 in Milan, Italy. Details of the oral presentation are as follows: Abstract Title: Stabilizers of CFTR NBD1 synergize with ...

McCray received the Trailblazer Award on Sept. 27 at the North American Cystic Fibrosis Conference in Boston. McCray has been working on gene therapy for cystic fibrosis since the early 1990s, he said ...

4DMT is a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. 4DMT’s ...